EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Failing Fontan Following Total Cavopulmonary Connection: Extracardiac Biomarkers Reveal 2 Distinct Phenotypes With Divergent Clinical Courses

Muneaki Matsubara iD, Havva Aldogan, Thibault Schaeffer iD, Christina Ruda, Christoph Röhlig, Jonas Palm iD, Nicole Piber, Alfred Hager iD, Peter Ewert iD, Jürgen Hörer, Masamichi Ono iD

Interdisciplinary CardioVascular and Thoracic Surgery · 03.08.2026 · 41 (8)

DOI: 10.1093/icvts/ivag213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, online erschienen am 30.07.2026. Verfasst von Muneaki Matsubara und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Congenital and Pediatric Heart Surgery, TUM University Hospital, German Heart Center, Munich, Germany; Division of Congenital and Pedia…. Hauptthemen laut MEDLINE: Fontan Procedure, Heart Defects, Congenital, Protein-Losing Enteropathies, Heart Failure. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Förderverein des Deutschen Herzzentrums München.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Failing Fontan is an increasingly recognized complication after total cavopulmonary connection (TCPC), yet longitudinal biomarker data remain scarce. We aimed to characterize the incidence, biomarker trajectories, and prognostic determinants of failing Fontan.

Methods

All patients who underwent primary TCPC (n = 650) or conversion to TCPC (n = 19) at our centre between 1994 and 2022 were reviewed. Lymphocyte count, N-terminal pro-brain natriuretic peptide (NT-proBNP) and its zlog value, and Fibrosis-4 index were assessed at 1 year before, 6 months before, at onset, and at last follow-up. Patients were classified into protein-losing enteropathy (PLE)/plastic bronchitis (PB) and heart failure phenotypes.

Results

Failing Fontan developed in 78 primary TCPC patients (12.0%) and 12 conversion patients (63.2%). Conversion patients developed failing Fontan earlier (P < .001), but survival after onset was comparable. Lymphocyte counts declined before onset (2.49 to 0.89 × 10³/µL, P < .001) and the Fibrosis-4 index increased (0.060 to 0.330, P < .001). Phenotypes showed divergent profiles: zlog-NT-proBNP at onset was 0.71 in PLE/PB versus 5.34 in heart failure (P < .001). Lymphocytopenia (LP) predicted mortality early (hazard ratio 6.77, P = .013) but appeared protective at last follow-up (hazard ratio 0.18, P = .049), reflecting a phenotypic shift. On multivariable analysis, lower lymphocyte count independently predicted mortality (hazard ratio 2.44, P = .041), while stent implantation was independently associated with lower mortality (hazard ratio 0.32, P = .040).

Conclusions

Lymphocyte counts and the Fibrosis-4 index change progressively before clinical onset and may serve as early warning biomarkers. The prognostic interpretation of LP depends on the underlying phenotype, underscoring the need for phenotype-aware monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fontan ProcedureHeart Defects, CongenitalProtein-Losing EnteropathiesHeart FailurePeptide FragmentsNatriuretic Peptide, BrainHeart Bypass, RightHumansFemaleBiomarkersMalePhenotypeTreatment FailureRetrospective StudiesChildLymphocyte CountRisk FactorsChild, PreschoolTime Factors

Stichwörter der Autor:innen

Fib 4NT-proBNPfailing Fontanlymphocytopeniatotal cavopulmonary connection

Substanzen

Biomarkerspro-brain natriuretic peptide (1-76)Peptide FragmentsNatriuretic Peptide, Brain

Autor:innen und Institutionen

  • Department of Congenital and Pediatric Heart Surgery, TUM University Hospital, German Heart Center, Munich, Germany; Division of Congenital and Pediatric Heart Surgery, University Hospital of Munich, Ludwig- Maximilians…
  • Department of Cardiovascular Surgery, Tokyo Metropolitan Children's Medical Center, Tokyo 183-8561, Japan.
  • Department of Congenital Heart Disease and Pediatric Cardiology, TUM University Hospital, German Heart Center, Munich 80636, Germany.
  • Department of Cardiovascular Surgery, TUM University Hospital, German Heart Center, Munich 80636, Germany.

ORCID-Profile: Muneaki Matsubara, Thibault Schaeffer, Jonas Palm, Alfred Hager, Peter Ewert, Masamichi Ono

Förderung

  • Förderverein des Deutschen Herzzentrums München

Zitieren

APA

Matsubara, M., Aldogan, H., Schaeffer, T., Ruda, C., Röhlig, C., Palm, J., Piber, N., Hager, A., Ewert, P., Hörer, J., & Ono, M. (2026). Failing Fontan Following Total Cavopulmonary Connection: Extracardiac Biomarkers Reveal 2 Distinct Phenotypes With Divergent Clinical Courses. Interdisciplinary CardioVascular and Thoracic Surgery, 41(8). https://doi.org/10.1093/icvts/ivag213

Vancouver

Matsubara M, Aldogan H, Schaeffer T, Ruda C, Röhlig C, Palm J, et al. Failing Fontan Following Total Cavopulmonary Connection: Extracardiac Biomarkers Reveal 2 Distinct Phenotypes With Divergent Clinical Courses. Interdisciplinary CardioVascular and Thoracic Surgery. 2026;41(8). doi:10.1093/icvts/ivag213

BibTeX
@article{Matsubara2026,
  author = {Matsubara, Muneaki and Aldogan, Havva and Schaeffer, Thibault and Ruda, Christina and Röhlig, Christoph and Palm, Jonas and Piber, Nicole and Hager, Alfred and Ewert, Peter and Hörer, Jürgen and Ono, Masamichi},
  title = {Failing Fontan Following Total Cavopulmonary Connection: Extracardiac Biomarkers Reveal 2 Distinct Phenotypes With Divergent Clinical Courses},
  journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
  year = {2026},
  volume = {41},
  number = {8},
  doi = {10.1093/icvts/ivag213}
}
Kostenlos starten →